• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β受体阻滞剂心肌梗死试验结束时的双盲评估。

Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.

作者信息

Byington R P, Curb J D, Mattson M E

出版信息

JAMA. 1985;253(12):1733-6.

PMID:3974051
Abstract

At the conclusion of a double-blinded, randomized clinical trial of propranolol hydrochloride, but before unblinding, the patients and clinic personnel were asked to guess the treatment group assignment of each patient. While 79.9% of the patients receiving propranolol correctly identified their treatment group assignment, 57.2% of the patients receiving placebo incorrectly guessed that they were also in the propranolol group. No specific mechanism was identified to explain why more patients receiving propranolol were better able to guess their group assignment. Clinic physicians correctly identified the group assignment of 69.9% of the patients receiving propranolol and 68.8% of the patients receiving placebo. Clinic coordinators correctly identified the group assignment of 67.1% of the patients receiving propranolol and 70.6% of the patients receiving placebo. For clinic personnel, heart rate level and heart rate change seem to be the mechanisms employed to identify their patients' treatment assignment.

摘要

在一项盐酸普萘洛尔双盲随机临床试验结束时,但在揭盲之前,要求患者和临床工作人员猜测每位患者的治疗组分配情况。接受普萘洛尔治疗的患者中有79.9%正确识别了自己的治疗组分配情况,而接受安慰剂治疗的患者中有57.2%错误地猜测自己也在普萘洛尔组。未发现具体机制来解释为什么更多接受普萘洛尔治疗的患者更能猜出自己的组分配情况。临床医生正确识别了接受普萘洛尔治疗的患者中的69.9%以及接受安慰剂治疗的患者中的68.8%的组分配情况。临床协调员正确识别了接受普萘洛尔治疗的患者中的67.1%以及接受安慰剂治疗的患者中的70.6%的组分配情况。对于临床工作人员而言,心率水平和心率变化似乎是他们识别患者治疗分配情况所采用的机制。

相似文献

1
Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.β受体阻滞剂心肌梗死试验结束时的双盲评估。
JAMA. 1985;253(12):1733-6.
2
The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.β受体阻滞剂心肌梗死试验。β受体阻滞剂心肌梗死研究组。
JAMA. 1981 Nov 6;246(18):2073-4.
3
Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.急性心肌梗死患者的普萘洛尔治疗:β受体阻滞剂心肌梗死试验
Circulation. 1983 Jun;67(6 Pt 2):I53-7.
4
Beta Blocker Heart Attack Trial: design features.
Control Clin Trials. 1981 Dec;2(4):275-85. doi: 10.1016/0197-2456(81)90018-0.
5
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.一项关于普萘洛尔治疗急性心肌梗死患者的随机试验。I. 死亡率结果。
JAMA. 1982 Mar 26;247(12):1707-14. doi: 10.1001/jama.1982.03320370021023.
6
Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.心肌梗死后的β受体阻滞剂治疗:挪威高危患者普萘洛尔研究
Circulation. 1983 Jun;67(6 Pt 2):I57-60.
7
Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
Control Clin Trials. 1984 Dec;5(4):382-437. doi: 10.1016/s0197-2456(84)80017-3.
8
A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.普萘洛尔治疗急性心肌梗死患者的随机试验。II. 发病率结果。
JAMA. 1983 Nov 25;250(20):2814-9. doi: 10.1001/jama.1983.03340200048027.
9
Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.在β受体阻滞剂心肌梗死试验中,首次发生心肌梗死且心电图ST段持续压低的患者使用普萘洛尔的效果。
Am Heart J. 1998 Feb;135(2 Pt 1):261-7. doi: 10.1016/s0002-8703(98)70091-2.
10
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.在β受体阻滞剂心肌梗死试验中普萘洛尔对非Q波急性心肌梗死的影响。
Am J Cardiol. 1990 Jul 15;66(2):129-33. doi: 10.1016/0002-9149(90)90575-l.

引用本文的文献

1
Can acupuncture treatment be double-blinded? An evaluation of double-blind acupuncture treatment of postoperative pain.针刺治疗能否采用双盲法?一项关于双盲针刺治疗术后疼痛的评估。
PLoS One. 2015 Mar 6;10(3):e0119612. doi: 10.1371/journal.pone.0119612. eCollection 2015.
2
A randomized, blinded, controlled trial investigating the gastrointestinal health effects of drinking water quality.一项调查饮用水质量对胃肠道健康影响的随机、双盲、对照试验。
Environ Health Perspect. 2001 Aug;109(8):773-8. doi: 10.1289/ehp.01109773.
3
Masking of physicians in the Growth Failure in Children with Renal Diseases Clinical Trial.
在儿童肾病生长发育不良临床试验中对医生进行设盲。
Pediatr Nephrol. 1993 Apr;7(2):204-6. doi: 10.1007/BF00864403.
4
Assessment of blindness in the Danish Verapamil Infarction Trial II (DAVIT II). Danish Study Group on Verapamil in Myocardial Infarction.丹麦维拉帕米梗死试验II(DAVIT II)中的失明评估。丹麦心肌梗死维拉帕米研究小组。
Eur J Clin Pharmacol. 1990;39(1):75-6. doi: 10.1007/BF02657062.